Inside the research

Medtronic plc

MDT Research profile · latest available data

Price overview

$88.64

▲ +0.85 (+1.0%)

52w hi$101.97
52w lo$72.50
Vol13.05M
As of25 Sep 2026

The Verdict

Buy

Our score +0.58

Short+0.52
Medium+0.62
Long+0.62

computed 2026-09-27

Key fundamentals

Medtronic plc

Healthcare · Medical Devices

Market cap$113.38B
Enterprise value$133.33B
Trailing P/E21.83x
Forward P/E13.84x
EV / EBITDA12.81x
P / S (ttm)3.02x
Profit margin13.9%
Return on equity10.6%
Revenue growth+13.7%
Earnings growth+40.7%
Debt / equity55.37

Layer Breakdown

LayerRawContribution
Fundamental+0.36
Sector+0.08
Technical+0.17
Earnings+0.00
Sentiment+0.42

macro × 1.00 · 2026-09-27

Business overview

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Ireland · www.medtronic.com

Risk Metrics

Beta vs SPX0.37
Corr SPX0.27
Annual vol22.5%
Annual ret+2.1%
Sharpe0.09
Max DD-30.0%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$108.00
High / Low$121.00 / $90.00
Median$110.00
Analysts25
Strong Buy4
Buy14
Hold11
Sell0
Strong Sell0

Recent rating actions

2026-04-22UBS→ Neutral
2026-04-15Truist Securities→ Hold
2026-04-13Mizuho→ Outperform
2026-04-09Evercore ISI Group→ Outperform
2026-04-07Citigroup→ Buy
2026-04-06Evercore ISI Group→ Outperform

Material Events

DateEvent8-K
2026-06-03Earnings Release, Exhibitsread
2026-05-18Officer / Director Change, Exhibitsread
2026-04-27Reg FD Disclosure, Exhibitsread
2026-03-24Reg FD Disclosureread
2026-02-17Earnings Release, Exhibitsread
2025-11-18Earnings Release, Exhibitsread
2025-11-03Officer / Director Changeread
2025-10-21Bylaws Amendment, Shareholder Vote…read
2025-09-29Material Agreement, Other Material Event…read
2025-09-16Reg FD Disclosure, Other Material Event…read
2025-08-19Earnings Release, Officer / Director Change…read
2025-06-23Officer / Director Changeread

Insider Trades

DateInsiderRoleActionSharesValue
2026-08-03Martha GeoffreyChairman and CEOGrant41.53K—
2026-08-03Pieton ThierryEVP & Chief Financial OffGrant11.54K—
2026-08-03Marinaro MichaelEVP, Pres MedSurg and AmeGrant46.15K—
2026-08-03KIIL HARRY SKIPEVP & President CardiovasGrant9.23K—
2026-08-03Thompson KweliEVP & President, NeurosciGrant6.92K—
2026-08-03Quinn MichelleEVP, GC and SecretaryGrant6.35K—
2026-08-03Blomquist Denise L.Chief Accounting OfficerGrant2.34K—
2026-08-03Marinaro MichaelEVP, Pres MedSurg and AmeGrant10.96K—
2026-08-03Walter Matthew R.SVP, Chief HR OfficerGrant5.77K—
2026-07-31Walter Matthew R.SVP, Chief HR OfficerWithheld for tax1.68K$143.03K

Flow & Concentration

Insider 180d net-$257.93K
Insider buys / sells0 / 1
Insider biasNeutral
13F holders10
Top-5 share92.0%
HHI4,041 (concentrated)

Top Holders

HolderValueShares
State Street Corp$5.01B63.40M
Norges Bank (Norway sovereign)$1.08B13.78M
Citadel Advisors$608.95M7.78M
Capital Research / Capital World$583.85M7.46M
Fidelity / FMR LLC$259.24M3.31M
AQR Capital Management$258.13M3.30M
Renaissance Technologies$247.81M3.17M
Millennium Management$113.99M1.46M
Bridgewater Associates$37.75M482.52K
T. Rowe Price Group$592.71K7.58M

As of 2026-06-30

Dividends

Yield (TTM)1.60%
$ / share (TTM)$1.42
5y CAGR+4.4%

Annual dividend per share

2021$2.47
2022$2.67
2023$2.75
2024$2.79
2025$2.83
2026$0.71

SEC Filings

DateFormDoc
2026-08-044view
2026-08-044view
2026-08-044view
2026-08-044view
2026-08-044view
2026-08-044view
2026-08-044view
2026-08-044view
2026-07-294view
2026-07-094view
2026-06-263view
2026-06-1810-Kview
2026-06-094view
2026-06-084view
2026-06-084view

The Long Run

FY 2015–2025 · 11 years

LineLatestCAGRTrend
Revenue$32.36B+6.9%
Gross profit$5.66B+12.3%
Operating income$5.14B+3.0%
Net income$3.76B+0.9%
Cash from ops$6.79B+3.0%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$87.61$88.99$87.12$88.6413.05M
Sep 24$89.74$90.28$88.46$88.5110.96M
Sep 23$90.53$91.15$88.61$89.3010.53M
Sep 22$92.51$92.67$90.55$90.7714.06M
Sep 21$91.50$92.73$91.50$91.757.31M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →